Ray Dalio acquired 29.8 Thousand Neogenomics shares worth $464 Thousand. That's 0.00% of their equity portfolio (694th largest holding). The first Neogenomics trade was made in Q1 2023. Since then Ray Dalio bought shares one more times and sold shares on two occasions. The stake costed the investor $428 Thousand, netting the investor a gain of 8.6% so far.